Company / Working Capital per Share
Ovid Therapeutics Inc. Working Capital per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.93
FY2025
5-year range
$0.64 / $1.77
FY2022-FY2025
Trend
+44.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $0.93.
Based on SEC 10-K filings.
0.93 in FY2025 with a 3-year CAGR of -19.3%.
Declined from $1.39 to $0.93 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -19.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 44.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.93 | +44.8% |
| FY2024 | $0.64 | -53.9% |
| FY2023 | $1.39 | -21.2% |
| FY2022 | $1.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026